Estimating benefit from dose dense adjuvant chemotherapy for early breast cancer in the PANTHER randomized phase 3 trial

被引：0
|
作者：
Matikas, Alexios
Gnant, Michael
Johansson, Hemming
Untch, Michael
Tsiknakis, Nikolaos
Greil, Richard
Loibl, Sibylle
Foukakis, Theodoros
Bergh, Jonas C. S.
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Karolinska Univ Hosp, Stockholm, Sweden
[3] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria
[4] Helios Klinikum Berlin Buch, Berlin, Germany
[5] Paracelsus Med Univ, Canc Cluster Salzburg, Ctr Clin Canc & Immunol Trials, Med Dept 3,Salzburg Canc Res Inst, Salzburg, Austria
[6] GBG Forsch GmbH, Neu Isenburg, Germany
[7] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[8] Karolinska Univ Hosp, Karolinska Comprehens Canc Ctr, Breast Canc Ctr, Canc Theme, Stockholm, Sweden
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
521
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trial
    Matikas, Alexios
    Papakonstantinou, Andri
    Loibl, Sibylle
    Steger, Guenther G.
    Untch, Michael
    Johansson, Hemming
    Tsiknakis, Nikos
    Hellstrom, Mats
    Greil, Richard
    Moebus, Volker
    Gnant, Michael
    Bergh, Jonas
    Foukakis, Theodoros
    LANCET REGIONAL HEALTH-EUROPE, 2025, 49
  • [2] Dose-dense adjuvant chemotherapy in early breast cancer patients: Results from a randomized trial
    Venturini, M
    Del Mastro, L
    Aitini, E
    Baldini, E
    Caroti, C
    Contu, A
    Testore, F
    Brema, F
    Pronzato, P
    Cavazzini, G
    Sertoli, MR
    Canavese, G
    Rosso, R
    Bruzzi, P
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (23): : 1724 - 1733
  • [3] Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer
    Papakonstantinou, Antroula
    Hedayati, Elham
    Hellstrom, Mats
    Johansson, Hemming
    Gnant, Michael
    Steger, GuEnther
    Greil, Richard
    Untch, Michael
    Moebus, Volker
    Loibl, Sibylle
    Foukakis, Theodoros
    Bergh, Jonas
    Matikas, Alexios
    ACTA ONCOLOGICA, 2020, 59 (01) : 75 - 81
  • [4] Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial
    Matikas, Alexios
    Moebus, Volker
    Greil, Richard
    Andersson, Anne
    Steger, Guenther G.
    Untch, Michael
    Fornander, Tommy
    Malmstroem, Per
    Schmatloch, Sabine
    Johansson, Hemming
    Hellstroem, Mats
    Brandberg, Yvonne
    Gnant, Michael
    Loibl, Sibylle
    Foukakis, Theodoros
    Bergh, Jonas
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (26)
  • [5] Efficacy and Safety of Tailored and Dose-Dense Adjuvant Chemotherapy and Trastuzumab for Resected HER2-Positive Breast Cancer: Results From the Phase 3 PANTHER Trial
    Papakonstantinou, Antroula
    Matikas, Alexios
    Bengtsson, Nils Olof
    Malmstrom, Per
    Hedayati, Elham
    Steger, Guenther
    Untch, Michael
    Hubbert, Laila
    Johansson, Hemming
    Hellstrom, Mats
    Gnant, Michael
    Loibl, Sibylle
    Greil, Richard
    Moebus, Volker
    Foukakis, Theodoros
    Bergh, Jonas
    CANCER, 2020, 126 (06) : 1175 - 1182
  • [6] Polychemotherapy for early breast cancer: Results from the international adjuvant breast cancer chemotherapy randomized trial
    不详
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (07): : 506 - 515
  • [7] Dose-dense adjuvant chemotherapy for breast cancer
    Ziegler, JoAnne
    Citron, Marc
    CANCER NURSING, 2006, 29 (04) : 266 - 272
  • [8] Adding Epoetin Alfa to Intense Dose-Dense Adjuvant Chemotherapy for Breast Cancer: Randomized Clinical Trial
    Moebus, Volker
    Jackisch, Christian
    Schneeweiss, Andreas
    Huober, Jens
    Lueck, Hans-Joachim
    du Bois, Andreas
    Thomssen, Christoph
    Kurbacher, Christian
    Kuhn, Walther
    Nitz, Ulrike
    Runnebaum, Ingo B.
    Hinke, Axel
    Kreienberg, Rolf
    Untch, Michael
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (14): : 1018 - 1026
  • [9] Randomised trial:: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer
    Kümmel, S
    Krocker, J
    Kohls, A
    Breitbach, GP
    Morack, G
    Budner, M
    Blohmer, JU
    Elling, D
    BRITISH JOURNAL OF CANCER, 2006, 94 (09) : 1237 - 1244
  • [10] Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer
    S Kümmel
    J Krocker
    A Kohls
    G-P Breitbach
    G Morack
    M Budner
    J-U Blohmer
    D Elling
    British Journal of Cancer, 2006, 94 : 1237 - 1244
12345